Cargando…

RUNX3 regulates vimentin expression via miR-30a during epithelial–mesenchymal transition in gastric cancer cells

Runt-related transcription factor 3 (RUNX3) is a putative tumour suppressor via regulating the expression of a series of target genes. Clinical studies demonstrated that loss of RUNX3 expression is associated with gastric cancer progression and poor prognosis, but the underlying mechanism is not ent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhifang, Chen, Long, Zhang, Xinchao, Xu, Xia, Xing, Huaixin, Zhang, Yingjie, Li, Wenjuan, Yu, Han, Zeng, Jiping, Jia, Jihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000113/ https://www.ncbi.nlm.nih.gov/pubmed/24447545 http://dx.doi.org/10.1111/jcmm.12209

Ejemplares similares

F-box protein FBXO31 is down-regulated in gastric cancer and negatively regulated by miR-17 and miR-20a
por: Zhang, Xinchao, et al.
Publicado: (2014)

miRNA‐532‐5p functions as an oncogenic microRNA in human gastric cancer by directly targeting RUNX3
por: Xu, Xia, et al.
Publicado: (2015)

The prognostic marker elastin correlates with epithelial–mesenchymal transition and vimentin‐positive fibroblasts in gastric cancer
por: Fang, Tianyi, et al.
Publicado: (2022)

Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
por: Usman, Saima, et al.
Publicado: (2021)

Helicobacter pylori Promotes Epithelial–Mesenchymal Transition in Gastric Cancer by Downregulating Programmed Cell Death Protein 4 (PDCD4)
por: Yu, Han, et al.
Publicado: (2014)

Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin
por: Dong, Qiongzhu, et al.
Publicado: (2016)

Significance of E-cadherin and Vimentin as epithelial-mesenchymal transition markers in colorectal carcinoma prognosis
por: Niknami, Zohreh, et al.
Publicado: (2020)

Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition
por: Hong, Deli, et al.
Publicado: (2017)

The association of vimentin and fibronectin gene expression with epithelial-mesenchymal transition and tumor malignancy in colorectal carcinoma
por: Niknami, Zohreh, et al.
Publicado: (2017)

MiR-22 suppresses epithelial–mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop
por: Xu, Mingjie, et al.
Publicado: (2018)

Restoration of miR-1228* Expression Suppresses Epithelial-Mesenchymal Transition in Gastric Cancer
por: Jia, Litao, et al.
Publicado: (2013)

MiR-30b is involved in methylglyoxal-induced epithelial-mesenchymal transition of peritoneal mesothelial cells in rats
por: Liu, Hong, et al.
Publicado: (2014)

Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA during epithelial–mesenchymal transitions and facilitates early metastasis
por: Francart, Marie-Emilie, et al.
Publicado: (2020)

Cisplatin resistance in gastric cancer cells is involved with GPR30‐mediated epithelial‐mesenchymal transition
por: Wang, Xiaofeng, et al.
Publicado: (2020)

Loss of E-cadherin and Acquisition of Vimentin in Epithelial-Mesenchymal Transition are Noble Indicators of Uterine Cervix Cancer Progression
por: Myong, Na-Hye
Publicado: (2012)

Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation
por: Liu, Ching-Yi, et al.
Publicado: (2015)

Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition
por: Monteiro-Reis, Sara, et al.
Publicado: (2023)

The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial–Mesenchymal Transition
por: Cao, Zi, et al.
Publicado: (2017)

LSD1 binds to HPV16 E7 and promotes the epithelial-mesenchymal transition in cervical cancer by demethylating histones at the Vimentin promoter
por: Liu, Yuan, et al.
Publicado: (2016)

MiR-30a Inhibits the Epithelial—Mesenchymal Transition of Podocytes through Downregulation of NFATc3
por: Peng, Rui, et al.
Publicado: (2015)

miR-665 Suppresses the Epithelial–Mesenchymal Transition and Progression of Gastric Cancer by Targeting CRIM1
por: Wu, Kun-Zhe, et al.
Publicado: (2020)

USP14 de-ubiquitinates vimentin and miR-320a modulates USP14 and vimentin to contribute to malignancy in gastric cancer cells
por: Zhu, Ying, et al.
Publicado: (2016)

DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells
por: Zhang, Lili, et al.
Publicado: (2018)

miR-574-5p mediates epithelial-mesenchymal transition in small cell lung cancer by targeting vimentin via a competitive endogenous RNA network
por: Sun, Yanqin, et al.
Publicado: (2021)

MiR‐30c protects diabetic nephropathy by suppressing epithelial‐to‐mesenchymal transition in db/db mice
por: Zhao, Yanru, et al.
Publicado: (2017)

Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial–mesenchymal transition-related proteins
por: Liu, Pei-Feng, et al.
Publicado: (2017)

Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression
por: Lobo, João, et al.
Publicado: (2020)

Association of E-cadherin & vimentin expression with clinicopathological parameters in lingual squamous cell carcinomas & their role in incomplete epithelial mesenchymal transition
por: Goyal, Neelakshi, et al.
Publicado: (2021)

Advanced Maternal Age‐associated SIRT1 Deficiency Compromises Trophoblast Epithelial−Mesenchymal Transition through an Increase in Vimentin Acetylation
por: Xiong, Liling, et al.
Publicado: (2021)

RUNX3 is down‐regulated in glioma by Myc‐regulated miR‐4295
por: Li, Xinxing, et al.
Publicado: (2016)

The SNAIL/miR-128 axis regulated growth, invasion, metastasis, and epithelial-to-mesenchymal transition of gastric cancer
por: Yu, Wei-Wei, et al.
Publicado: (2017)

CEACAM5 targeted by miR-498 promotes cell proliferation, migration and epithelial to mesenchymal transition in gastric cancer
por: Zhang, Liang, et al.
Publicado: (2022)

Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer
por: Chen, Jia, et al.
Publicado: (2014)

The miR-370/UQCRC2 axis facilitates tumorigenesis by regulating epithelial-mesenchymal transition in Gastric Cancer
por: Wang, Dan-wen, et al.
Publicado: (2020)

Histone demethylase RBP2 induced by Helicobactor Pylori CagA participates in the malignant transformation of gastric epithelial cells
por: Liang, Xiuming, et al.
Publicado: (2014)

In wound repair vimentin mediates the transition of mesenchymal leader cells to a myofibroblast phenotype
por: Walker, J. L., et al.
Publicado: (2018)

miR-122 inhibits metastasis and epithelial–mesenchymal transition of non-small-cell lung cancer cells
por: Qin, Haifeng, et al.
Publicado: (2015)

The coordinated roles of miR-26a and miR-30c in regulating TGFβ1-induced epithelial-to-mesenchymal transition in diabetic nephropathy
por: Zheng, Zongji, et al.
Publicado: (2016)

MEG3/miR-21 axis affects cell mobility by suppressing epithelial-mesenchymal transition in gastric cancer
por: Xu, Gang, et al.
Publicado: (2018)

miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression
por: Song, Guangyuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o9eca45ep4qi7ui94qipbk2l8i